Silexion Therapeutics (SLXN)

Silexion Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

163K

Short interest

settlement 2026-10-15

1.0

Days to cover

unchanged vs prior

45.2%

Short share of volume

2026-11-02

375

Fails to deliver

settlement 2026-10-08

Wed 11 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in SLXN is 162,704 shares, down 75,913 shares over the last month. Over the last 48 readings it ranged from 13,090 shares (15 July 2026) to 4,925,958 shares (30 September 2026). The latest reading sits at the bottom of that range. At the reported average volume of 1.6M shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/slxn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	162,704	-96.7%	1,598,172	1.00
2026-09-30	4,925,958	+1964.4%	40,442,760	1.00
2026-09-15	238,617	+1545.5%	15,566,949	1.00
2026-08-31	14,501	-87.8%	257,490	1.00
2026-08-14	119,287	+460.4%	927,154	1.00
2026-07-31	21,284	+62.6%	111,194	1.00
2026-07-15	13,090	-4.7%	21,092	1.00
2026-06-30	13,737	-17.0%	118,248	1.00
2026-06-15	16,557	-89.3%	233,740	1.00
2026-05-29	154,973	-2.5%	3,772,319	1.00
2026-05-15	159,027	+380.1%	476,377	1.00
2026-04-30	33,126	-28.7%	96,152	1.00
2026-04-15	46,472	-6.9%	70,577	1.00
2026-03-31	49,913	+5.2%	47,096	1.06
2026-03-13	47,438	+4.5%	27,905	1.70
2026-02-27	45,388	-18.6%	16,711	2.72
2026-02-13	55,759	+20.7%	33,262	1.68
2026-01-30	46,202	-4.7%	38,290	1.21
2026-01-15	48,495	+2.0%	63,050	1.00
2025-12-31	47,547	-39.8%	57,964	1.00
2025-12-15	78,920	-29.7%	51,039	1.55
2025-11-28	112,215	+22.9%	73,586	1.52
2025-11-14	91,327	-37.3%	65,455	1.40
2025-10-31	145,745	-4.6%	51,475	2.83
2025-10-15	152,730	+428.7%	147,270	1.04
2025-09-30	28,888	-74.5%	653,721	1.00
2025-09-15	113,258	+470.9%	1,988,881	1.00
2025-08-29	19,840	-29.5%	21,103	1.00
2025-08-15	28,141	+31.4%	66,168	1.00
2025-07-31	21,418	-96.5%	194,972	1.00
2025-07-15	619,429	+72.5%	1,321,742	1.00
2025-06-30	359,103	+14.0%	111,584	3.22
2025-06-13	315,007	-66.1%	244,107	1.29
2025-05-30	929,778	+120.0%	2,189,915	1.00
2025-05-15	422,661	-45.5%	204,605	2.07
2025-04-30	775,098	+194.5%	7,060,357	1.00
2025-04-15	263,179	-29.9%	227,005	1.16
2025-03-31	375,527	-11.5%	1,072,375	1.00
2025-03-14	424,328	-56.5%	9,331,571	1.00
2025-02-28	976,476	+217.9%	10,646,354	1.00
2025-02-14	307,157	-80.8%	3,055,111	1.00
2025-01-31	1,597,588	+618.2%	55,069,732	1.00
2025-01-15	222,445	+482.5%	1,842,343	1.00
2024-12-31	38,190	-81.1%	716,483	1.00
2024-12-13	202,541	+234.8%	1,309,773	1.00
2024-11-29	60,494	-81.3%	2,650,960	1.00
2024-11-15	322,582	-58.0%	488,892	1.00
2024-10-31	767,744	+762.9%	2,293,996	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of SLXN volume is 45.2%, down 15.4 points over the last five sessions. Over the last 30 readings it ranged from 9.3% (28 October 2026) to 60.5% (26 October 2026). The latest reading is 4.4 points above the 30-session average of 40.7%, on 178K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	80K	178K	45.2%	0
2026-10-30	240K	510K	47.0%	0
2026-10-29	74K	152K	48.6%	0
2026-10-28	8K	90K	9.3%	0
2026-10-27	128K	436K	29.4%	23,903
2026-10-26	393K	650K	60.5%	96,519
2026-10-23	814K	1.4M	59.3%	2,090
2026-10-22	94K	291K	32.1%	0
2026-10-21	66K	126K	52.7%	0
2026-10-20	242K	578K	41.9%	0
2026-10-19	610K	1.3M	45.9%	22,907
2026-10-16	223K	459K	48.6%	21,709
2026-10-15	940K	1.7M	54.2%	556
2026-10-14	112K	352K	32.0%	0
2026-10-13	243K	553K	44.0%	6,548
2026-10-12	200K	601K	33.3%	47,959
2026-10-09	162K	332K	48.8%	73,039
2026-10-08	278K	823K	33.7%	18,597
2026-10-07	132K	428K	30.9%	6,042
2026-10-06	81K	387K	21.1%	3,307
2026-10-05	192K	617K	31.1%	0
2026-10-02	382K	962K	39.7%	45,821
2026-10-01	333K	1.0M	33.3%	58,927
2026-09-30	1.4M	3.8M	37.5%	115,759
2026-09-29	37.0M	64.6M	57.3%	266,951
2026-09-28	656K	1.4M	45.9%	1,100
2026-09-25	107K	397K	26.9%	5,233
2026-09-24	265K	718K	37.0%	48,876
2026-09-23	1.4M	2.4M	57.2%	168,817
2026-09-22	2.4M	6.4M	38.0%	294,833

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 8 October 2026, the fails-to-deliver balance in SLXN is 375 shares, down 7,285 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (4 August 2026) to 1,853,952 shares (30 September 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-08	375	$0.25	$94
2026-10-07	7,660	$0.26	$2K
2026-10-05	82,653	$0.26	$21K
2026-10-01	74,699	$0.28	$21K
2026-09-30	1,853,952	$0.32	$593K
2026-09-29	565,896	$0.25	$141K
2026-09-28	1,992	$0.26	$518
2026-09-25	1,992	$0.26	$518
2026-09-24	140,990	$0.32	$45K
2026-09-23	179,395	$0.39	$70K
2026-09-22	9,698	$0.54	$5K
2026-09-21	46,349	$0.44	$20K
2026-09-17	21,866	$0.34	$7K
2026-09-16	29,615	$0.34	$10K
2026-09-14	79,917	$0.36	$29K
2026-09-11	230,460	$0.42	$97K
2026-09-08	4,462	$0.35	$2K
2026-09-01	613	$0.37	$227
2026-08-27	2,738	$0.35	$958
2026-08-18	200	$0.42	$84
2026-08-17	36,466	$0.42	$15K
2026-08-14	22,094	$0.46	$10K
2026-08-13	10,794	$0.45	$5K
2026-08-12	154,183	$1.04	$160K
2026-08-11	10,634	$1.50	$16K
2026-08-04	1	$1.87	$2
2026-07-17	55	$2.71	$149
2026-07-08	851	$2.74	$2K
2026-07-07	568	$2.85	$2K
2026-07-06	2,738	$2.65	$7K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for SLXN in the last 90 days. The most recent filings are listed below. Latest filing: Shirvan Mitchell (CSO and CDO) on 2026-06-04.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-06-04	Shirvan Mitchell	CSO and CDO	Grant	6K	$0.00	$0	9K
2026-06-04	Horenshtein Hadar Mirit	CFO and Secretary	Grant	8K	$0.00	$0	13K
2026-06-04	Hadar Ilan	Chairman and CEO	Grant	10K	$0.00	$0	17K
2026-03-26	Shirvan Mitchell	CSO and CDO	Sell	23K	$1.36	$31K	28K
2026-02-20	Shirvan Mitchell	CSO and CDO	Grant	50K	$0.00	$0	51K
2026-02-20	Peled Amnon	Director	Grant	8K	$0.00	$0	8K
2026-02-20	Lushi Avner	Director	Grant	9K	$0.00	$0	25K
2026-02-20	Horenshtein Hadar Mirit	CFO and Secretary	Grant	50K	$0.00	$0	50K
2026-02-20	Hadar Ilan	Chairman and CEO	Grant	64K	$0.00	$0	65K
2026-02-20	Alon Ruth	Director	Grant	9K	$0.00	$0	10K
2026-02-20	Abramov Dror Yosef	Director	Grant	9K	$0.00	$0	10K
2026-02-20	Noy Shlomo	Director	Grant	9K	$0.00	$0	25K
2025-09-15	Moringa Sponsor, LP	TenPercentOwner	Grant	450K	$4.00	$1.8M	457K
2025-09-15	Levin Ilan	Director, 10% owner	Grant	450K	$4.00	$1.8M	457K
2025-08-07	Moringa Sponsor, LP	TenPercentOwner	Other transaction	6K	$0.00	$0	7K
2025-08-07	Levin Ilan	Director, 10% owner	Other transaction	6K	$0.00	$0	7K
2025-02-09	Peled Amnon	Director	Grant	661	$0.00	$0	661
2025-02-09	Noy Shlomo	Director	Grant	2K	$0.00	$0	2K
2025-02-09	Lushi Avner	Director	Grant	2K	$0.00	$0	2K
2025-02-09	Alon Ruth	Director	Grant	794	$0.00	$0	794
2025-02-09	Abramov Dror Yosef	Director	Grant	794	$0.00	$0	794

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

4 holders report 5% or more of SLXN in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is Moringa Partners Ltd at 17.7% of the class (1,954,056 shares), filed 2026-09-28 for an event on 2026-09-18.

Filed	Form	Holder	Shares	Of class	Event
2026-09-28	13D/Ano. 5	Moringa Partners Ltdcorporation	2.0M	17.7%	2026-09-18
2026-09-28	13D/Ano. 5	Ilan Levinindividual	2.0M	17.7%	2026-09-18
2026-09-28	13D/Ano. 5	Moringa Sponsor, LPpartnership	2.0M	17.7%	2026-09-18
2026-08-18	13G	Mitchell P. Kopinparent holding company, individual	287K	5.0%	2026-08-11
2026-08-18	13G	Daniel B. Asherparent holding company, individual	287K	5.0%	2026-08-11
2026-08-18	13G	Intracoastal Capital LLCother entity	287K	5.0%	2026-08-11
2026-05-15	13G/Ano. 2	Lind Global Partners III LLCpartnership	213K	5.0%	2026-03-31
2026-05-15	13G/Ano. 2	EASTON JEFFindividual	213K	5.0%	2026-03-31
2026-05-15	13G/Ano. 2	Lind Global Fund III LPpartnership	213K	5.0%	2026-03-31
2025-09-15	13G	Lincoln Alternative Strategies LLCother entity	131K	6.2%	2025-09-12
2025-09-15	13G/Ano. 1	Orca Capital AGcorporation	109K	4.9%	2025-09-11

What this page is

Silexion Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Silexion Therapeutics (SLXN), SEC CIK 2022416, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-28.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-04.JSON and CSV
Company record: EDGAR filing index for CIK 2022416Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of SLXN is sold short?

162,704 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is SLXN's daily short volume?

On 2026-11-02, 80,209 of the 177,627 SLXN shares reported to FINRA were sold short, 45.2% of the day's reported volume. Short volume is a flow for one day, not a position.

Does SLXN have fails to deliver?

The SEC's latest file shows 375 SLXN shares failed to deliver at settlement 2026-10-08. Fails are reported per settlement date and published twice a month with a lag.

Are SLXN insiders buying or selling?

No open-market insider trades were reported for SLXN in the last 90 days. The most recent filings are listed below. Latest filing: Shirvan Mitchell (CSO and CDO) on 2026-06-04.

Who owns 5% or more of SLXN?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Silexion Therapeutics (SLXN)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

Silexion Therapeutics in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions